New-onset Graves’ disease following SARS-CoV-2 vaccination: a case report
A 22-year-old male with a history of ulcerative colitis and nephrotic syndrome treated with immunomodulatory agents including vedolizumab and mycophenolic acid developed hyperthyroidism 2 weeks following the first administration of BNT162b2 vaccine (Pfizer- BioNTech COVID-19 vaccine). Graves’ diseas...
Main Authors: | Ringo Manta, Charlotte Martin, Vinciane Muls, Kris G Poppe |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2023-01-01
|
Series: | European Thyroid Journal |
Subjects: | |
Online Access: | https://etj.bioscientifica.com/view/journals/etj/11/4/ETJ-22-0049.xml |
Similar Items
-
Recurrence of Graves’ Disease (a Th1-type Cytokine Disease) Following SARS-CoV-2 mRNA Vaccine Administration: A Simple Coincidence?
by: Guillaume Pierman, et al.
Published: (2021-09-01) -
Graves‘ disease following vaccination against SARS-CoV-2: A systematic review of the reported cases
by: Konstantinos Katsikas Triantafyllidis, et al.
Published: (2022-09-01) -
Graves’ Disease Following SARS-CoV-2 Vaccination: A Systematic Review
by: Armando Patrizio, et al.
Published: (2022-09-01) -
New-onset and relapsed Graves’ disease following COVID-19 vaccination: a comprehensive review of reported cases
by: Kan Chen, et al.
Published: (2023-07-01) -
A Postoperative Man with Marfan Syndrome with Palpitations and Chest Pain After Receiving the SARS-CoV-2 Vaccine
by: Li K, et al.
Published: (2021-07-01)